Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria.
作者信息
Kirienko Natalia V, Rahme Laurence, Cho You-Hee
机构信息
Department of BioSciences, Rice University, Houston, TX, United States.
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
出版信息
Front Cell Infect Microbiol. 2019 Oct 11;9:343. doi: 10.3389/fcimb.2019.00343. eCollection 2019.
Abstract
摘要
相似文献
1
Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria.
Front Cell Infect Microbiol. 2019 Oct 11;9:343. doi: 10.3389/fcimb.2019.00343. eCollection 2019.
2
Quorum sensing pathways in Gram-positive and -negative bacteria: potential of their interruption in abating drug resistance.
J Chemother. 2019 Jul;31(4):161-187. doi: 10.1080/1120009X.2019.1599175. Epub 2019 Apr 22.
3
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.
Drug Des Devel Ther. 2016 May 27;10:1795-806. doi: 10.2147/DDDT.S98939. eCollection 2016.
4
Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.
Int J Mol Sci. 2019 Apr 13;20(8):1838. doi: 10.3390/ijms20081838.
5
Antivirulence compounds: a future direction to overcome antibiotic resistance?
Future Microbiol. 2020 Mar;15:299-301. doi: 10.2217/fmb-2019-0294.
6
Bacterial quorum sensing: a new target for anti-infective immunotherapy.
Expert Opin Biol Ther. 2008 Jun;8(6):719-24. doi: 10.1517/14712598.8.6.719.
7
Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR.
Curr Drug Discov Technol. 2020;17(4):430-447. doi: 10.2174/1570163816666190304122219.
8
Can resistance against quorum-sensing interference be selected?
ISME J. 2016 Jan;10(1):4-10. doi: 10.1038/ismej.2015.84. Epub 2015 May 29.
9
Quorum sensing: a new prospect for the management of antimicrobial-resistant infectious diseases.
Expert Rev Anti Infect Ther. 2021 May;19(5):571-586. doi: 10.1080/14787210.2021.1843427. Epub 2020 Dec 8.
10
Microbial Biofilm and Quorum Sensing Inhibition: Endowment of Medicinal Plants to Combat Multidrug-Resistant Bacteria.
Curr Drug Targets. 2018;19(16):1916-1932. doi: 10.2174/1389450119666180406111143.
引用本文的文献
1
Innovative perspectives on the discovery of small molecule antibiotics.
NPJ Antimicrob Resist. 2025 Mar 13;3(1):19. doi: 10.1038/s44259-025-00089-0.
2
Small-Molecule Antibiotic Drug Development: Need and Challenges.
ACS Infect Dis. 2023 Nov 10;9(11):2062-2071. doi: 10.1021/acsinfecdis.3c00189. Epub 2023 Oct 11.
3
Exploring the modulatory impact of isosakuranetin on : Inhibition of sortase A activity and α-haemolysin expression.
Virulence. 2023 Dec;14(1):2260675. doi: 10.1080/21505594.2023.2260675. Epub 2023 Sep 28.
4
Comparative Evaluation of Assays for Broad Detection of Molecular Resistance Mechanisms in Isolates.
J Clin Microbiol. 2021 Oct 19;59(11):e0103321. doi: 10.1128/JCM.01033-21. Epub 2021 Aug 18.
5
Evaluation of Antiviral, Antibacterial and Antiproliferative Activities of the Endophytic Fungus , and Isolation of a New Polyhydroxyacid.
Microorganisms. 2020 Sep 4;8(9):1353. doi: 10.3390/microorganisms8091353.
6
Supramolecular Peptide Assemblies as Antimicrobial Scaffolds.
Molecules. 2020 Jun 14;25(12):2751. doi: 10.3390/molecules25122751.
本文引用的文献
1
Pyoverdine-Dependent Virulence of Isolates From Cystic Fibrosis Patients.
Front Microbiol. 2019 Sep 6;10:2048. doi: 10.3389/fmicb.2019.02048. eCollection 2019.
2
The fall and rise of phage therapy in modern medicine.
Expert Opin Biol Ther. 2019 Nov;19(11):1115-1117. doi: 10.1080/14712598.2019.1651287. Epub 2019 Aug 9.
3
Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms.
Trends Microbiol. 2019 Sep;27(9):739-752. doi: 10.1016/j.tim.2019.04.006. Epub 2019 May 22.
4
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
Front Microbiol. 2019 Apr 1;10:539. doi: 10.3389/fmicb.2019.00539. eCollection 2019.
5
Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
Viruses. 2019 Mar 18;11(3):268. doi: 10.3390/v11030268.
6
The GAIN Act legislation to combat antimicrobial resistance: Where do we stand?
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1499-1500. doi: 10.1017/ice.2018.252. Epub 2018 Oct 18.
7
What are the economic barriers of antibiotic R&D and how can we overcome them?
Expert Opin Drug Discov. 2018 Oct;13(10):889-892. doi: 10.1080/17460441.2018.1515908. Epub 2018 Sep 1.
8
Antimicrobial Stewardship and Antimicrobial Resistance.
Med Clin North Am. 2018 Sep;102(5):805-818. doi: 10.1016/j.mcna.2018.04.004. Epub 2018 Jul 14.
9
Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles and in a Murine Model of Experimental Vaginitis.
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.02576-17. Print 2018 Aug.
10
Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response.
Virulence. 2018 Dec 31;9(1):804-817. doi: 10.1080/21505594.2018.1449508.
Zotero 插件